Jon Risfelt new President of Gambro Renal Products

Jon Risfelt new President of Gambro Renal Products Stockholm, Sweden, October 30, 2003 Gambro AB (Stockholmsbörsen: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that Jon Risfelt has been elected acting President of Gambro Renal Products. He is succeeding Alain Granger, who has decided to move to a position as senior advisor to the company. Jon Risfelt has a broad experience from management positions in international companies. Recently he was President and CEO of Vodafone Sweden. He joins Gambro as of November 3, 2003. Jon Risfelt has many years of management experience from products and service industry in several types of businesses like financial services, travel and airline industry and the telecommunication area. His extensive and successful career includes management positions in Vodafone, American Express, Scandinavian Airlines and Ericsson. Jon Risfelt is Board Member of companies active in logistics, travel and software. He is 42 years old and holds a Master of Science degree in Chemical Engineering from the Royal Institute of Technology, Stockholm. "With 25 years in the company Alain Granger has played a key role in developing Gambro Renal Products to where it is today as a globally leading provider of renal products," says Sören Mellstig, President and CEO of Gambro. "I want to thank him for his almost lifelong contribution to our company. I look forward to have his continued support in his role as senior advisor to the company." Gambro Renal Products has revenues of about USD 1.3 billion and includes products and services for hemo- and peritoneal dialysis and acute dialysis. Sales include activities in 90 countries, with own sales operations in 28 countries. Manufacturing takes place in 12 countries with product development centers in Germany, Italy and Sweden. The total number of employees is about 7,100. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 33, +46-70-513 65 33 Pia Irell, Investor Relations Director, Corporate Finance, tel. +46-8-613 65 91, +46-70-513 65 91 Kevin Smith, President Gambro Inc., Investor Relations US, tel. +1-303 231 4750 Link to photograph of Jon Risfelt: http://www.gambro.com/jon_risfelt/ ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/10/30/20031030BIT00650/wkr0001.doc http://www.waymaker.net/bitonline/2003/10/30/20031030BIT00650/wkr0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe